Masthead
 

Custom Search
ADVERTISEMENT
Today's Health Photos
NEW YORK (Reuters Health) - Snowboarders who use personal music players while boarding have fewer injuries but the injuries they do sustain tend to be more severe, reports a new study from Canada.

NEW YORK (Reuters Health) - At most colleges, campus police refer students involved in alcohol-related incidents to school officials for discipline rather than taking legal action, according to a study of 343 U.S. schools.

ABUJA/GENEVA (Reuters) - A Liberian man who died in Nigeria's commercial capital Lagos on Friday tested positive for the deadly Ebola virus, Health Minister Onyebuchi Chukwu said.

NEW YORK (Reuters Health) - Parents of overweight and obese kids may want to help their kids be healthier, but they’re more often willing to make changes in children’s diets than in their activity levels, according to a new study.

(Reuters) - Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema.

HONG KONG (Reuters) - McDonald's Corp has suspended sales of chicken nuggets and other items in Hong Kong after it said it imported products from Shanghai Husi Food, the U.S.-owned Chinese company at the center of a food safety scare in China.

WASHINGTON (Reuters) - Overall U.S. food inflation will remain near the historic norm in 2014, even as prices for meat and seafood are pushed higher by disease and widespread drought, the U.S. Department of Agriculture said on Friday.

NEW YORK (Reuters Health) - Teenagers are more likely to discuss topics like sexual health and drug use with their doctors if their parents are out of the room for at least part of their check-up, a new study shows.

LONDON (Reuters) - Two new leukemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

FRANKFURT (Reuters) - German drugmaker Bayer said a Phase III trial of cancer drug Nexavar in patients with advanced breast cancer did not meet its primary endpoint of delaying the progression of the disease.

ADVERTISEMENT
Log into your Thames Valley Portal
Video
loading